GlassScriptPhysician profile
Michael J Pelletier
NPI 1841295672
$2,107.56
in general payments reported to CMS, 2019-2025
29 companies · $665 in 2025
The $665 reported for 2025 was more than what 86% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $181 · 2020: $63.22 · 2021: $179 · 2022: $197 · 2023: $395 · 2024: $427 · 2025: $665.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,395 · Education: $91.65.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,395.00 |
| Education | $91.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $326.11 | 2023-2025 | Veozah |
| Abbvie INC. | $286.60 | 2019-2023 | |
| Hologic Sales and Service, LLC | $152.06 | 2019-2025 | Aptima, Sonata Sonography-Guided Transcervical Fibroid Ablation System, Fluent Fluid Management System |
| Millicent US INC | $125.33 | 2023-2024 | Intrarosa, Femring |
| Organon LLC | $122.54 | 2022-2025 | Nexplanon |
| Bayer Healthcare Pharmaceuticals INC. | $119.68 | 2023-2025 | |
| Medtronic, INC. | $105.88 | 2023-2025 | Ligasure, Interstim |
| Mayne Pharma Commercial LLC | $92.06 | 2022-2023 | |
| Aspira Women'S Health INC | $78.45 | 2021 | |
| Shield Therapeutics INC | $78.42 | 2023-2025 | Accrufer |
| Daiichi Sankyo INC. | $72.86 | 2019-2025 | Injectafer |
| Conmed Corporation | $63.79 | 2025 | Airseal |
| Stryker Corporation | $62.47 | 2024 | Aequalis Ascend Flex |
| Exeltis, USA INC. | $60.71 | 2023-2025 | Slynd |
| Pacira Pharmaceuticals Incorporated | $54.89 | 2019-2023 | Exparel |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $42.86 | 2023-2024 | Cologuard Collection Kit |
| Coopersurgical, INC. | $35.92 | 2019-2024 | Paragard T 380a |
| Avanos Medical | $32.07 | 2019 | |
| Sumitomo Pharma America, INC. | $28.97 | 2025 | Myfembree |
| Meditrina | $23.05 | 2023-2024 | |
| Monaghan Medical Corporation | $19.52 | 2023 | Aerochamber |
| Boston Scientific Corporation | $19.27 | 2019 | |
| Minerva Surgical, INC | $17.57 | 2025 | |
| Myovant Sciences INC. | $16.35 | 2021 | |
| Duchesnay USA Incorporated | $15.68 | 2019 | |
| Olympus America INC. | $15.60 | 2022 | |
| Allergan, INC. | $14.51 | 2019 | |
| Evofem Biosciences, INC. | $12.78 | 2022 | |
| Cumberland Pharmaceuticals, INC. | $11.56 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Pelletier listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.